APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antifungal Drugs for Skin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antifungal Drugs for Skin Industry Growth and Trends Forecast to 2032

27 December 2025121 pages

Choose your research edition.

Industry ResearchAntifungal Drugs for Skin Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Antifungal Drugs for Skin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Antifungal Drugs for Skin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antifungal Drugs for Skin Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Antifungal Drugs for Skin Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Antifungal Drugs for Skin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antifungal Drugs for Skin include Aden Healthcare, AdvaCare Pharma, Amar Healthcare, AS lifesciences, Dr. Reddy's Laboratories, Pfizer, Shree Ganesh Remedies, Solisom Healthcare and Wellona Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antifungal Drugs for Skin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antifungal Drugs for Skin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antifungal Drugs for Skin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antifungal Drugs for Skin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antifungal Drugs for Skin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antifungal Drugs for Skin Market by Company

Aden Healthcare

AdvaCare Pharma

Amar Healthcare

AS lifesciences

Dr. Reddy's Laboratories

Pfizer

Shree Ganesh Remedies

Solisom Healthcare

Wellona Pharma

Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.

Harbin Labton Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Bioengineering Co., Ltd.

Hubei Hengan Fulin Pharmaceutical Co., Ltd.

Jiangsu Chenpai Pharmaceutical Group Co., Ltd.

Livzon Group Livzon Pharmaceutical Factory

Lunan Beite Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.

Shandong Chenxin Fodu Pharmaceutical Co., Ltd.

Shandong Fangming Pharmaceutical Group Co., Ltd.

Shanghai Baolong Pharmaceutical Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Yunnan Longrun Pharmaceutical Co., Ltd.

Zhejiang East Asia Pharmaceutical Co., Ltd.

Antifungal Drugs for Skin Segment by Type

Amorolfine

Butenafine

Ciprofloxacin

Clotrimazole

Miconazole

Terbinafine

Ketoconazole

Econazole

Other

Antifungal Drugs for Skin Segment by Application

Hospital

Clinic

Other

Antifungal Drugs for Skin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antifungal Drugs for Skin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antifungal Drugs for Skin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antifungal Drugs for Skin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antifungal Drugs for Skin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antifungal Drugs for Skin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Amorolfine Table 2. Major Company of Butenafine Table 3. Major Company of Ciprofloxacin Table 4. Major Company of Clotrimazole Table 5. Major Company of Miconazole Table 6. Major Company of Terbinafine Table 7. Major Company of Ketoconazole Table 8. Major Company of Econazole Table 9. Major Company of Other Table 10. Global Antifungal Drugs for Skin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 11. Global Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 12. Global Antifungal Drugs for Skin Sales Market Share in Volume by Type (2021-2026) Table 13. Global Antifungal Drugs for Skin Sales by Type (2021-2026) & (US$ Million) Table 14. Global Antifungal Drugs for Skin Sales Market Share in Value by Type (2021-2026) Table 15. Global Antifungal Drugs for Skin Price by Type (2021-2026) & (US$/Unit) Table 16. Global Antifungal Drugs for Skin Sales by Type (2027-2032) & (K Units) Table 17. Global Antifungal Drugs for Skin Sales Market Share in Volume by Type (2027-2032) Table 18. Global Antifungal Drugs for Skin Sales by Type (2027-2032) & (US$ Million) Table 19. Global Antifungal Drugs for Skin Sales Market Share in Value by Type (2027-2032) Table 20. Global Antifungal Drugs for Skin Price by Type (2027-2032) & (US$/Unit) Table 21. North America Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 22. North America Antifungal Drugs for Skin Sales by Type (2021-2026) & (US$ Million) Table 23. Europe Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 24. Europe Antifungal Drugs for Skin Sales by Type (2021-2026) & (US$ Million) Table 25. Asia-Pacific Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 26. Asia-Pacific Antifungal Drugs for Skin Sales by Type (2021-2026) & (US$ Million) Table 27. Latin America Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 28. Latin America Antifungal Drugs for Skin Sales by Type (2021-2026) & (US$ Million) Table 29. Middle East and Africa Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 30. Middle East and Africa Antifungal Drugs for Skin Sales by Type (2021-2026) & (US$ Million) Table 31. Antifungal Drugs for Skin Industry Trends Table 32. Antifungal Drugs for Skin Industry Drivers Table 33. Antifungal Drugs for Skin Industry Opportunities and Challenges Table 34. Antifungal Drugs for Skin Industry Restraints Table 35. Global Antifungal Drugs for Skin Sales Revenue by Company (US$ Million) & (2021-2026) Table 36. Global Antifungal Drugs for Skin Revenue Market Share by Company (2021-2026) Table 37. Global Antifungal Drugs for Skin Sales by Company (2021-2026) & (K Units) Table 38. Global Antifungal Drugs for Skin Sales Share by Company (2021-2026) Table 39. Global Antifungal Drugs for Skin Market Price by Company (2021-2026) & (US$/Unit) Table 40. Global Antifungal Drugs for Skin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 41. Global Antifungal Drugs for Skin Major Company Production Sites and Headquarters Table 42. Global Antifungal Drugs for Skin Company, Product Type & Application Table 43. Global Antifungal Drugs for Skin Company Establishment Date Table 44. Global Company Market Concentration Ratio (CR5 and HHI) Table 45. Global Antifungal Drugs for Skin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 46. Global Antifungal Drugs for Skin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 47. Global Antifungal Drugs for Skin Sales by Region (2021-2026) & (K Units) Table 48. Global Antifungal Drugs for Skin Sales Market Share in Volume by Region (2021-2026) Table 49. Global Antifungal Drugs for Skin Sales by Region (2021-2026) & (US$ Million) Table 50. Global Antifungal Drugs for Skin Sales Market Share in Value by Region (2021-2026) Table 51. Global Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 52. Global Antifungal Drugs for Skin Sales by Region (2027-2032) & (K Units) Table 53. Global Antifungal Drugs for Skin Sales Market Share in Volume by Region (2027-2032) Table 54. Global Antifungal Drugs for Skin Sales by Region (2027-2032) & (US$ Million) Table 55. Global Antifungal Drugs for Skin Sales Market Share in Value by Region (2027-2032) Table 56. Global Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 57. Global Antifungal Drugs for Skin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 58. Global Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 59. Global Antifungal Drugs for Skin Sales Market Share in Volume by Application (2021-2026) Table 60. Global Antifungal Drugs for Skin Sales by Application (2021-2026) & (US$ Million) Table 61. Global Antifungal Drugs for Skin Sales Market Share in Value by Application (2021-2026) Table 62. Global Antifungal Drugs for Skin Price by Application (2021-2026) & (US$/Unit) Table 63. Global Antifungal Drugs for Skin Sales by Application (2027-2032) & (K Units) Table 64. Global Antifungal Drugs for Skin Sales Market Share in Volume by Application (2027-2032) Table 65. Global Antifungal Drugs for Skin Sales by Application (2027-2032) & (US$ Million) Table 66. Global Antifungal Drugs for Skin Sales Market Share in Value by Application (2027-2032) Table 67. Global Antifungal Drugs for Skin Price by Application (2027-2032) & (US$/Unit) Table 68. North America Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 69. North America Antifungal Drugs for Skin Sales by Application (2021-2026) & (US$ Million) Table 70. Europe Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 71. Europe Antifungal Drugs for Skin Sales by Application (2021-2026) & (US$ Million) Table 72. Asia-Pacific Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 73. Asia-Pacific Antifungal Drugs for Skin Sales by Application (2021-2026) & (US$ Million) Table 74. Latin America Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 75. Latin America Antifungal Drugs for Skin Sales by Application (2021-2026) & (US$ Million) Table 76. Middle East and Africa Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 77. Middle East and Africa Antifungal Drugs for Skin Sales by Application (2021-2026) & (US$ Million) Table 78. Aden Healthcare Company Information Table 79. Aden Healthcare Business Overview Table 80. Aden Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Aden Healthcare Antifungal Drugs for Skin Product Portfolio Table 82. Aden Healthcare Recent Development Table 83. AdvaCare Pharma Company Information Table 84. AdvaCare Pharma Business Overview Table 85. AdvaCare Pharma Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio Table 87. AdvaCare Pharma Recent Development Table 88. Amar Healthcare Company Information Table 89. Amar Healthcare Business Overview Table 90. Amar Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Amar Healthcare Antifungal Drugs for Skin Product Portfolio Table 92. Amar Healthcare Recent Development Table 93. AS lifesciences Company Information Table 94. AS lifesciences Business Overview Table 95. AS lifesciences Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AS lifesciences Antifungal Drugs for Skin Product Portfolio Table 97. AS lifesciences Recent Development Table 98. Dr. Reddy's Laboratories Company Information Table 99. Dr. Reddy's Laboratories Business Overview Table 100. Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio Table 102. Dr. Reddy's Laboratories Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Pfizer Antifungal Drugs for Skin Product Portfolio Table 107. Pfizer Recent Development Table 108. Shree Ganesh Remedies Company Information Table 109. Shree Ganesh Remedies Business Overview Table 110. Shree Ganesh Remedies Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio Table 112. Shree Ganesh Remedies Recent Development Table 113. Solisom Healthcare Company Information Table 114. Solisom Healthcare Business Overview Table 115. Solisom Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Solisom Healthcare Antifungal Drugs for Skin Product Portfolio Table 117. Solisom Healthcare Recent Development Table 118. Wellona Pharma Company Information Table 119. Wellona Pharma Business Overview Table 120. Wellona Pharma Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Wellona Pharma Antifungal Drugs for Skin Product Portfolio Table 122. Wellona Pharma Recent Development Table 123. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information Table 124. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview Table 125. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 127. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Development Table 128. Harbin Labton Pharmaceutical Co., Ltd. Company Information Table 129. Harbin Labton Pharmaceutical Co., Ltd. Business Overview Table 130. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 132. Harbin Labton Pharmaceutical Co., Ltd. Recent Development Table 133. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information Table 134. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview Table 135. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 137. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Development Table 138. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information Table 139. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview Table 140. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 142. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Development Table 143. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information Table 144. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview Table 145. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 147. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Development Table 148. Livzon Group Livzon Pharmaceutical Factory Company Information Table 149. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 150. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio Table 152. Livzon Group Livzon Pharmaceutical Factory Recent Development Table 153. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 154. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 155. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 157. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 158. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 159. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 160. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 162. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Development Table 163. Qilu Pharmaceutical Co., Ltd. Company Information Table 164. Qilu Pharmaceutical Co., Ltd. Business Overview Table 165. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 167. Qilu Pharmaceutical Co., Ltd. Recent Development Table 168. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information Table 169. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview Table 170. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 172. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Development Table 173. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information Table 174. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview Table 175. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 177. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Development Table 178. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information Table 179. Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview Table 180. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 182. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Development Table 183. Shanghai Baolong Pharmaceutical Co., Ltd. Company Information Table 184. Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview Table 185. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 186. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 187. Shanghai Baolong Pharmaceutical Co., Ltd. Recent Development Table 188. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 189. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 190. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 191. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 192. Teyi Pharmaceutical Group Co., Ltd. Recent Development Table 193. Southwest Pharmaceutical Co., Ltd. Company Information Table 194. Southwest Pharmaceutical Co., Ltd. Business Overview Table 195. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 196. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 197. Southwest Pharmaceutical Co., Ltd. Recent Development Table 198. Yunnan Longrun Pharmaceutical Co., Ltd. Company Information Table 199. Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview Table 200. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 201. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 202. Yunnan Longrun Pharmaceutical Co., Ltd. Recent Development Table 203. Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information Table 204. Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview Table 205. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 206. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 207. Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Development Table 208. North America Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 209. North America Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 210. North America Antifungal Drugs for Skin Sales Market Share by Country (2021-2026) Table 211. North America Antifungal Drugs for Skin Sales Forecast by Country (2027-2032) & (K Units) Table 212. North America Antifungal Drugs for Skin Sales Market Share Forecast by Country (2027-2032) Table 213. North America Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. North America Antifungal Drugs for Skin Market Size by Country (2021-2026) & (US$ Million) Table 215. North America Antifungal Drugs for Skin Market Share by Country (2021-2026) Table 216. North America Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. North America Antifungal Drugs for Skin Market Share Forecast by Country (2027-2032) Table 218. Europe Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 219. Europe Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 220. Europe Antifungal Drugs for Skin Sales Market Share by Country (2021-2026) Table 221. Europe Antifungal Drugs for Skin Sales Forecast by Country (2027-2032) & (K Units) Table 222. Europe Antifungal Drugs for Skin Sales Market Share Forecast by Country (2027-2032) Table 223. Europe Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 224. Europe Antifungal Drugs for Skin Market Size by Country (2021-2026) & (US$ Million) Table 225. Europe Antifungal Drugs for Skin Market Share by Country (2021-2026) Table 226. Europe Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 227. Europe Antifungal Drugs for Skin Market Share Forecast by Country (2027-2032) Table 228. Asia-Pacific Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 229. Asia-Pacific Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 230. Asia-Pacific Antifungal Drugs for Skin Sales Market Share by Country (2021-2026) Table 231. Asia-Pacific Antifungal Drugs for Skin Sales Forecast by Country (2027-2032) & (K Units) Table 232. Asia-Pacific Antifungal Drugs for Skin Sales Market Share Forecast by Country (2027-2032) Table 233. Asia-Pacific Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 234. Asia-Pacific Antifungal Drugs for Skin Market Size by Country (2021-2026) & (US$ Million) Table 235. Asia-Pacific Antifungal Drugs for Skin Market Share by Country (2021-2026) Table 236. Asia-Pacific Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 237. Asia-Pacific Antifungal Drugs for Skin Market Share Forecast by Country (2027-2032) Table 238. Latin America Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 239. Latin America Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 240. Latin America Antifungal Drugs for Skin Sales Market Share by Country (2021-2026) Table 241. Latin America Antifungal Drugs for Skin Sales Forecast by Country (2027-2032) & (K Units) Table 242. Latin America Antifungal Drugs for Skin Sales Market Share Forecast by Country (2027-2032) Table 243. Latin America Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 244. Latin America Antifungal Drugs for Skin Market Size by Country (2021-2026) & (US$ Million) Table 245. Latin America Antifungal Drugs for Skin Market Share by Country (2021-2026) Table 246. Latin America Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 247. Latin America Antifungal Drugs for Skin Market Share Forecast by Country (2027-2032) Table 248. Middle East and Africa Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 249. Middle East and Africa Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 250. Middle East and Africa Antifungal Drugs for Skin Sales Market Share by Country (2021-2026) Table 251. Middle East and Africa Antifungal Drugs for Skin Sales Forecast by Country (2027-2032) & (K Units) Table 252. Middle East and Africa Antifungal Drugs for Skin Sales Market Share Forecast by Country (2027-2032) Table 253. Middle East and Africa Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 254. Middle East and Africa Antifungal Drugs for Skin Market Size by Country (2021-2026) & (US$ Million) Table 255. Middle East and Africa Antifungal Drugs for Skin Market Share by Country (2021-2026) Table 256. Middle East and Africa Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 257. Middle East and Africa Antifungal Drugs for Skin Market Share Forecast by Country (2027-2032) Table 258. Key Raw Materials Table 259. Raw Materials Key Suppliers Table 260. Antifungal Drugs for Skin Distributors List Table 261. Antifungal Drugs for Skin Customers List Table 262. Research Programs/Design for This Report Table 263. Authors List of This Report Table 264. Secondary Sources Table 265. Primary Sources List of Figures Figure 1. Antifungal Drugs for Skin Image Figure 2. Global Antifungal Drugs for Skin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antifungal Drugs for Skin Market Size (2021-2032) & (US$ Million) Figure 4. Global Antifungal Drugs for Skin Sales (2021-2032) & (K Units) Figure 5. Amorolfine Image Figure 6. Global Amorolfine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Butenafine Image Figure 8. Global Butenafine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Ciprofloxacin Image Figure 10. Global Ciprofloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Clotrimazole Image Figure 12. Global Clotrimazole Sales YoY Growth (2021-2032) & (K Units) Figure 13. Miconazole Image Figure 14. Global Miconazole Sales YoY Growth (2021-2032) & (K Units) Figure 15. Terbinafine Image Figure 16. Global Terbinafine Sales YoY Growth (2021-2032) & (K Units) Figure 17. Ketoconazole Image Figure 18. Global Ketoconazole Sales YoY Growth (2021-2032) & (K Units) Figure 19. Econazole Image Figure 20. Global Econazole Sales YoY Growth (2021-2032) & (K Units) Figure 21. Other Image Figure 22. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 23. Global Antifungal Drugs for Skin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 24. Global Antifungal Drugs for Skin Market Share by Type 2025 VS 2032 Figure 25. North America Antifungal Drugs for Skin Sales Market Share in Volume by Type in 2025 Figure 26. North America Antifungal Drugs for Skin Sales Market Share in Value by Type in 2025 Figure 27. Europe Antifungal Drugs for Skin Sales Market Share in Volume by Type in 2025 Figure 28. Europe Antifungal Drugs for Skin Sales Market Share in Value by Type in 2025 Figure 29. Asia-Pacific Antifungal Drugs for Skin Sales Market Share in Volume by Type in 2025 Figure 30. Asia-Pacific Antifungal Drugs for Skin Sales Market Share in Value by Type in 2025 Figure 31. Latin America Antifungal Drugs for Skin Sales Market Share in Volume by Type in 2025 Figure 32. Latin America Antifungal Drugs for Skin Sales Market Share in Value by Type in 2025 Figure 33. Middle East and Africa Antifungal Drugs for Skin Sales Market Share in Volume by Type in 2025 Figure 34. Middle East and Africa Antifungal Drugs for Skin Sales Market Share in Value by Type in 2025 Figure 35. Global Top 5 and 10 Antifungal Drugs for Skin Players Market Share by Revenue in 2025 Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 37. Hospital Image Figure 38. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 39. Clinic Image Figure 40. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 41. Other Image Figure 42. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 43. Global Antifungal Drugs for Skin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Antifungal Drugs for Skin Market Share by Application 2025 VS 2032 Figure 45. North America Antifungal Drugs for Skin Sales Market Share in Volume by Application in 2025 Figure 46. North America Antifungal Drugs for Skin Sales Market Share in Value by Application in 2025 Figure 47. Europe Antifungal Drugs for Skin Sales Market Share in Volume by Application in 2025 Figure 48. Europe Antifungal Drugs for Skin Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Antifungal Drugs for Skin Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Antifungal Drugs for Skin Sales Market Share in Value by Application in 2025 Figure 51. Latin America Antifungal Drugs for Skin Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Antifungal Drugs for Skin Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Antifungal Drugs for Skin Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Antifungal Drugs for Skin Sales Market Share in Value by Application in 2025 Figure 55. North America Antifungal Drugs for Skin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. North America Antifungal Drugs for Skin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Antifungal Drugs for Skin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antifungal Drugs for Skin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Europe Antifungal Drugs for Skin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Antifungal Drugs for Skin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Antifungal Drugs for Skin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Asia-Pacific Antifungal Drugs for Skin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Antifungal Drugs for Skin Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Antifungal Drugs for Skin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Latin America Antifungal Drugs for Skin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Antifungal Drugs for Skin Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Antifungal Drugs for Skin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Middle East and Africa Antifungal Drugs for Skin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Antifungal Drugs for Skin Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Antifungal Drugs for Skin Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Antifungal Drugs for Skin Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Amorolfine
  • Butenafine
  • Ciprofloxacin
  • Clotrimazole
  • Miconazole
  • Terbinafine
  • Ketoconazole
  • Econazole
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aden Healthcare
  • AdvaCare Pharma
  • Amar Healthcare
  • AS lifesciences
  • Dr. Reddy's Laboratories
  • Pfizer
  • Shree Ganesh Remedies
  • Solisom Healthcare
  • Wellona Pharma
  • Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  • Harbin Labton Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  • Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  • Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  • Livzon Group Livzon Pharmaceutical Factory
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  • Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  • Shandong Fangming Pharmaceutical Group Co., Ltd.
  • Shanghai Baolong Pharmaceutical Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Yunnan Longrun Pharmaceutical Co., Ltd.
  • Zhejiang East Asia Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antifungal Drugs for Skin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antifungal Drugs for Skin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antifungal Drugs for Skin Market by Type
  6. 1.3.1 Amorolfine
  7. 1.3.2 Butenafine
  8. 1.3.3 Ciprofloxacin
  9. 1.3.4 Clotrimazole
  10. 1.3.5 Miconazole
  11. 1.3.6 Terbinafine
  12. 1.3.7 Ketoconazole
  13. 1.3.8 Econazole
  14. 1.3.9 Other
  15. 1.4 Global Antifungal Drugs for Skin Market Size by Type
  16. 1.4.1 Global Antifungal Drugs for Skin Market Size Overview by Type (2021-2032)
  17. 1.4.2 Global Antifungal Drugs for Skin Historic Market Size Review by Type (2021-2026)
  18. 1.4.3 Global Antifungal Drugs for Skin Forecasted Market Size by Type (2027-2032)
  19. 1.5 Key Regions Market Size by Type
  20. 1.5.1 North America Antifungal Drugs for Skin Sales Breakdown by Type (2021-2026)
  21. 1.5.2 Europe Antifungal Drugs for Skin Sales Breakdown by Type (2021-2026)
  22. 1.5.3 Asia-Pacific Antifungal Drugs for Skin Sales Breakdown by Type (2021-2026)
  23. 1.5.4 South America Antifungal Drugs for Skin Sales Breakdown by Type (2021-2026)
  24. 1.5.5 Middle East and Africa Antifungal Drugs for Skin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antifungal Drugs for Skin Industry Trends
  2. 2.2 Antifungal Drugs for Skin Industry Drivers
  3. 2.3 Antifungal Drugs for Skin Industry Opportunities and Challenges
  4. 2.4 Antifungal Drugs for Skin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antifungal Drugs for Skin Revenue (2021-2026)
  2. 3.2 Global Top Players by Antifungal Drugs for Skin Sales (2021-2026)
  3. 3.3 Global Top Players by Antifungal Drugs for Skin Price (2021-2026)
  4. 3.4 Global Antifungal Drugs for Skin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antifungal Drugs for Skin Major Company Production Sites & Headquarters
  6. 3.6 Global Antifungal Drugs for Skin Company, Product Type & Application
  7. 3.7 Global Antifungal Drugs for Skin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antifungal Drugs for Skin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antifungal Drugs for Skin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antifungal Drugs for Skin Tier 1, Tier 2, and Tier 3
4 Antifungal Drugs for Skin Regional Status and Outlook
  1. 4.1 Global Antifungal Drugs for Skin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antifungal Drugs for Skin Historic Market Size by Region
  3. 4.2.1 Global Antifungal Drugs for Skin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antifungal Drugs for Skin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antifungal Drugs for Skin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antifungal Drugs for Skin Forecasted Market Size by Region
  7. 4.3.1 Global Antifungal Drugs for Skin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antifungal Drugs for Skin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antifungal Drugs for Skin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antifungal Drugs for Skin by Application
  1. 5.1 Antifungal Drugs for Skin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Antifungal Drugs for Skin Market Size by Application
  6. 5.2.1 Global Antifungal Drugs for Skin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antifungal Drugs for Skin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antifungal Drugs for Skin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antifungal Drugs for Skin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antifungal Drugs for Skin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antifungal Drugs for Skin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antifungal Drugs for Skin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antifungal Drugs for Skin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aden Healthcare
  2. 6.1.1 Aden Healthcare Company Information
  3. 6.1.2 Aden Healthcare Business Overview
  4. 6.1.3 Aden Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aden Healthcare Antifungal Drugs for Skin Product Portfolio
  6. 6.1.5 Aden Healthcare Recent Developments
  7. 6.2 AdvaCare Pharma
  8. 6.2.1 AdvaCare Pharma Company Information
  9. 6.2.2 AdvaCare Pharma Business Overview
  10. 6.2.3 AdvaCare Pharma Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio
  12. 6.2.5 AdvaCare Pharma Recent Developments
  13. 6.3 Amar Healthcare
  14. 6.3.1 Amar Healthcare Company Information
  15. 6.3.2 Amar Healthcare Business Overview
  16. 6.3.3 Amar Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amar Healthcare Antifungal Drugs for Skin Product Portfolio
  18. 6.3.5 Amar Healthcare Recent Developments
  19. 6.4 AS lifesciences
  20. 6.4.1 AS lifesciences Company Information
  21. 6.4.2 AS lifesciences Business Overview
  22. 6.4.3 AS lifesciences Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AS lifesciences Antifungal Drugs for Skin Product Portfolio
  24. 6.4.5 AS lifesciences Recent Developments
  25. 6.5 Dr. Reddy's Laboratories
  26. 6.5.1 Dr. Reddy's Laboratories Company Information
  27. 6.5.2 Dr. Reddy's Laboratories Business Overview
  28. 6.5.3 Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio
  30. 6.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Antifungal Drugs for Skin Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Shree Ganesh Remedies
  38. 6.7.1 Shree Ganesh Remedies Company Information
  39. 6.7.2 Shree Ganesh Remedies Business Overview
  40. 6.7.3 Shree Ganesh Remedies Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio
  42. 6.7.5 Shree Ganesh Remedies Recent Developments
  43. 6.8 Solisom Healthcare
  44. 6.8.1 Solisom Healthcare Company Information
  45. 6.8.2 Solisom Healthcare Business Overview
  46. 6.8.3 Solisom Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Solisom Healthcare Antifungal Drugs for Skin Product Portfolio
  48. 6.8.5 Solisom Healthcare Recent Developments
  49. 6.9 Wellona Pharma
  50. 6.9.1 Wellona Pharma Company Information
  51. 6.9.2 Wellona Pharma Business Overview
  52. 6.9.3 Wellona Pharma Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Wellona Pharma Antifungal Drugs for Skin Product Portfolio
  54. 6.9.5 Wellona Pharma Recent Developments
  55. 6.10 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  56. 6.10.1 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  60. 6.10.5 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Harbin Labton Pharmaceutical Co., Ltd.
  62. 6.11.1 Harbin Labton Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Harbin Labton Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  66. 6.11.5 Harbin Labton Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  68. 6.12.1 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information
  69. 6.12.2 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview
  70. 6.12.3 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  72. 6.12.5 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Developments
  73. 6.13 Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  74. 6.13.1 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  78. 6.13.5 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  80. 6.14.1 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information
  81. 6.14.2 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview
  82. 6.14.3 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  84. 6.14.5 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Developments
  85. 6.15 Livzon Group Livzon Pharmaceutical Factory
  86. 6.15.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  87. 6.15.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  88. 6.15.3 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio
  90. 6.15.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  91. 6.16 Lunan Beite Pharmaceutical Co., Ltd.
  92. 6.16.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  96. 6.16.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Nanjing Chengong Pharmaceutical Co., Ltd.
  98. 6.17.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  102. 6.17.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Qilu Pharmaceutical Co., Ltd.
  104. 6.18.1 Qilu Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  108. 6.18.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  110. 6.19.1 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  114. 6.19.5 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments
  115. 6.20 Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  116. 6.20.1 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
  117. 6.20.2 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview
  118. 6.20.3 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  120. 6.20.5 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments
  121. 6.21 Shandong Fangming Pharmaceutical Group Co., Ltd.
  122. 6.21.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
  123. 6.21.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview
  124. 6.21.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  126. 6.21.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments
  127. 6.22 Shanghai Baolong Pharmaceutical Co., Ltd.
  128. 6.22.1 Shanghai Baolong Pharmaceutical Co., Ltd. Company Information
  129. 6.22.2 Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview
  130. 6.22.3 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  132. 6.22.5 Shanghai Baolong Pharmaceutical Co., Ltd. Recent Developments
  133. 6.23 Teyi Pharmaceutical Group Co., Ltd.
  134. 6.23.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  135. 6.23.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  136. 6.23.3 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  138. 6.23.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  139. 6.24 Southwest Pharmaceutical Co., Ltd.
  140. 6.24.1 Southwest Pharmaceutical Co., Ltd. Company Information
  141. 6.24.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  142. 6.24.3 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  144. 6.24.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  145. 6.25 Yunnan Longrun Pharmaceutical Co., Ltd.
  146. 6.25.1 Yunnan Longrun Pharmaceutical Co., Ltd. Company Information
  147. 6.25.2 Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview
  148. 6.25.3 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  150. 6.25.5 Yunnan Longrun Pharmaceutical Co., Ltd. Recent Developments
  151. 6.26 Zhejiang East Asia Pharmaceutical Co., Ltd.
  152. 6.26.1 Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information
  153. 6.26.2 Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview
  154. 6.26.3 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  156. 6.26.5 Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Antifungal Drugs for Skin Sales by Country
  2. 7.1.1 North America Antifungal Drugs for Skin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antifungal Drugs for Skin Sales by Country (2021-2026)
  4. 7.1.3 North America Antifungal Drugs for Skin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antifungal Drugs for Skin Market Size by Country
  6. 7.2.1 North America Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antifungal Drugs for Skin Market Size by Country (2021-2026)
  8. 7.2.3 North America Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antifungal Drugs for Skin Sales by Country
  2. 8.1.1 Europe Antifungal Drugs for Skin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antifungal Drugs for Skin Sales by Country (2021-2026)
  4. 8.1.3 Europe Antifungal Drugs for Skin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antifungal Drugs for Skin Market Size by Country
  6. 8.2.1 Europe Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antifungal Drugs for Skin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antifungal Drugs for Skin Sales by Country
  2. 9.1.1 Asia-Pacific Antifungal Drugs for Skin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antifungal Drugs for Skin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antifungal Drugs for Skin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antifungal Drugs for Skin Market Size by Country
  6. 9.2.1 Asia-Pacific Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antifungal Drugs for Skin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antifungal Drugs for Skin Sales by Country
  2. 10.1.1 South America Antifungal Drugs for Skin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antifungal Drugs for Skin Sales by Country (2021-2026)
  4. 10.1.3 South America Antifungal Drugs for Skin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antifungal Drugs for Skin Market Size by Country
  6. 10.2.1 South America Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antifungal Drugs for Skin Market Size by Country (2021-2026)
  8. 10.2.3 South America Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antifungal Drugs for Skin Sales by Country
  2. 11.1.1 Middle East and Africa Antifungal Drugs for Skin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antifungal Drugs for Skin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antifungal Drugs for Skin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antifungal Drugs for Skin Market Size by Country
  6. 11.2.1 Middle East and Africa Antifungal Drugs for Skin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antifungal Drugs for Skin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antifungal Drugs for Skin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antifungal Drugs for Skin Value Chain Analysis
  2. 12.1.1 Antifungal Drugs for Skin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antifungal Drugs for Skin Production Mode & Process
  7. 12.2 Antifungal Drugs for Skin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antifungal Drugs for Skin Distributors
  10. 12.2.3 Antifungal Drugs for Skin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst